DDS-04F:
Propofol (Intravenous Formulation)

Our Product

We are developing a novel, lipid- and preservative-free formulation of propofol, which addresses the limitations of currently marketed products while adding the potential benefits of multi-use vials and pain-free injection. In addition, our formulation provides the potential for improved safety, increased stability, reduced wastage and cost, multiple dose usage, easy storage and reconstitution.

Market Opportunity

Propofol is the most widely used intravenous anaesthetic in the world, with global sales of more than US$822 million in 2007. Demand for propofol is expected to grow based on demographics and a projected increase in the number of surgical procedures, as well as greater usage in the ambulatory care setting and endoscopy procedures.

Status

We have completed feasibility and formulation and are seeking a partner for the next phase of development.